17 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Community-Acquired Pneumonia ... • Combination therapy ... fluoroquinolone #IDSA ... #Antibiotics #Treatment
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Infections • Pulmonary ... count <50 • Pulmonary ... of starting OI treatment ... Antiretroviral #Therapy ... Infections #management #infectiousdiseases
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... therapy for patients ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... Regimens #Duration #IDSA
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
of organizing pneumonia ... , Pulmonary lymphoma ... Treatment: • ... steroids: Cytotoxic Therapy ... #COP #BOOP #pulmonary
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #pharmacology #IDSA ... #Guidelines #Treatment
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Quick Reference - Treatment ... Streptococcus Pneumoniae ... 10-14 days therapy ... #Bacteremia #Treatment ... Management #Duration #infectiousdiseases
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... against Pneumocystis pneumonia ... /ml Preferred Therapy ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
procalcitonin level Treatment ... for continued therapy ... for continued therapy ... Diagnosis #Management #treatment ... #Pulmonary #Community
The 2007 Infectious Disease Society of America (IDSA)/American Thoracic Society (ATS) recommendations list macrolides as first
Society of America (IDSA ... as first line therapy ... considered when S. pneumonia ... #InfectiousDiseases
Invasive Aspergillus (IA) - Diagnosis and Management
Aspergillus is ubiquitous in nature. Most invasive infections are caused
are caused by members ... presentations: • Pulmonary ... this morphology Treatment ... Diagnosis #Management #treatment ... #fungal #infectiousdiseases